SCHEMBL3198809

SCHEMBL3198809

COC1C(CC(=O)c2ccccc2)=CC(C)=C1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
POLB P06746 2/20 0.43
SMN1; SMN2 Q16637 4/20 0.42
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 3/20 0.42
MAPT P10636 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
HTT P42858 2/20 0.42
APAF1 O14727 1/20 0.42
MITF O75030 1/20 0.42
NPC1 O15118 7/20 0.39
KMT2A Q03164 6/20 0.39
MEN1 O00255 5/20 0.39
RAB9A P51151 5/20 0.39
PLAU P00749 1/20 0.38
MAPK1 P28482 2/20 0.38
HPGD P15428 2/20 0.38
CYP3A4 P08684 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3214650 0.79 L3MBTL1 (0.44) LMNAPOLBSMN1; SMN2ALDH1A1KDM4E
SCHEMBL3213340 0.78 MAPT (0.43) LMNASMN1; SMN2ALDH1A1KDM4EMAPT
SCHEMBL3202460 0.77 LMNA (0.43) LMNAPOLBSMN1; SMN2ALDH1A1KDM4E
SCHEMBL3216909 0.75 L3MBTL1 (0.47) LMNAPOLBSMN1; SMN2ALDH1A1KDM4E
SCHEMBL3200031 0.73 LMNA (0.40) LMNAPOLBSMN1; SMN2ALDH1A1KDM4E
SCHEMBL3214879 0.69 PLOD2 (0.41) LMNAPOLBSMN1; SMN2ALDH1A1KDM4E
SCHEMBL3212473 0.68 CES1 (0.38) LMNAPOLBSMN1; SMN2ALDH1A1KDM4E
SCHEMBL3209904 0.68 MAPT (0.42) LMNAPOLBSMN1; SMN2ALDH1A1KDM4E
SCHEMBL3199965 0.67 ALDH1A1 (0.42) LMNASMN1; SMN2ALDH1A1KDM4EMAPT
Methoxymethane SCHEMBL27486318 0.67 MAPT (0.63) LMNAPOLBSMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732643-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-06-08 US disclosed
US-7671226-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-03-02 US disclosed
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME HANAOKA HIDENORI 2010-02-25 US disclosed
EP-1426379-B1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME SUMITOMO CHEMICAL CO (JP) 2009-11-11 EP disclosed
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same HANAOKA HIDENORI 2009-02-26 US disclosed
US-7439379-B2 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL CO., LTD. (JP) 2008-10-21 US disclosed
US-20040242410-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-12-02 US disclosed
EP-1426379-A1 TRANSITION METAL COMPLEX,CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME Sumitomo Chemical Company, Limited (JP) 2004-06-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054607-A1 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same C1R, C1S, AP1M1 LMNA 2849/4885POLB 964/4885SMN1; SMN2 3599/4885
US-20100048933-A1 TRANSITION METAL COMPLEX, CATALYST FOR OLEFIN POLYMERIZATION, AND PROCESS FOR PRODUCING OLEFIN POLYMER WITH THE SAME C1R, C1S, AP1M1 LMNA 2849/4885POLB 964/4885SMN1; SMN2 3599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.